WisdomTree (NASDAQ: WETF) explored a sale and held talks with JPMorgan (NYSE: JPM) last year, according to Bloomberg, citing people familiar with the matter.

Talks ended in December because the parties couldn't agree on price, as shared tumbled amid a rout in U.S. stocks.

WisdomTree is no longer actively pursing a sale but could seek to put itself back on the block as shares rebound.

About 700 people were evacuated on Friday from two different towns in the Brazilian state of Minas Gerais where a dam collapse last month killed at least 157 people, with nearly 200 still missing and feared dead.
As many as 7 out of 10 people with type 2 diabetes can achieve long-term disease remission by having weight-loss surgery called gastric bypass, according to a new Danish study.
The surgery isn't necessarily a cure for type 2 diabetes. Some people who go into remission and appear to no longer have the disease can relapse and start having symptoms again. In this study, 27 percent of people who were in remission relapsed during the five-year follow-up.

SINGAPORE (Feb 8): Iron ore futures surged more than 5% to hit the highest level since 2014 on concern that the increasingly severe crisis at top producer Vale SA will curtail global supplies, tightening the seaborne market and offsetting the impact of a slowdown in China, the largest importer.

Vale invoked force majeure earlier this week, after a judge forced it to suspend some operations at its Brucutu mine in Brazil — a move that it said would result in an annual production loss of 30 million tons. That’s on top an earlier reduction of 40 million tons, following a deadly dam burst. In addition, Vale’s license to operate a dam at Brucutu was revoked by a state regulator.

Vale (NYSE:VALE) had its price target cut by Royal Bank of Canada to $9.00 in a research report released on Monday, The Fly reports. They currently have an underperform rating on the basic materials company’s stock.

A number of other research analysts have also recently commented on VALE. Jefferies Financial Group cut Vale from a buy rating to a hold rating and lowered their price target for the stock from $18.00 to $14.00 in a report on Monday, January 28th. HSBC cut Vale from a buy rating to a hold rating and lowered their price target for the stock from $18.00 to $14.50 in a report on Monday, January 28th. Barclays set a $16.00 price target on Vale and gave the stock a buy rating in a report on Thursday, January 10th. ValuEngine raised Vale from a sell rating to a hold rating in a report on Monday. Finally, BMO Capital Markets cut Vale from an outperform rating to a market perform rating and lowered their price target for the stock from $15.00 to $13.00 in a report on Monday, January 28th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of $13.98.